Thermo Fisher launches TaqPath COVID-19 2.0 test

Create PDF

June 24, 2021—Thermo Fisher Scientific launched its CE-IVD-marked TaqPath COVID-19 Fast PCR Combo Kit 2.0. The kit uses an advanced assay design that compensates for current and emerging variants, the company says, by using eight targets across three genomic regions of the virus to help ensure the test provides accurate results even as the virus mutates.

“We are working to empower our customers to prepare for the next stage of the pandemic by future-proofing our test design against likely mutations and to provide continued confidence in their results,” Manoj Gandhi, MD, PhD, senior medical director, genetic sciences, Thermo Fisher, said in a press statement.